| |
| |
|
| Insider
Information: |
Green David |
| Relationship: |
Interim CEO, Director |
| City: |
Holliston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,084,432 |
|
|
Indirect Shares
|
251,364 |
|
|
| Direct
Value |
$3,543,266 |
|
|
|
Indirect Value
|
$843,899 |
|
|
| Total
Shares |
1,335,796 |
|
|
| Total
Value |
$4,387,165 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 49.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harvard Bioscience Inc |
HBIO |
Director |
2017-02-07 |
925,571 |
2017-02-07 |
234,896 |
Premium* |
|
|
Biostage Inc |
BSTG |
Interim CEO, Director |
2022-05-12 |
158,861 |
2022-05-12 |
16,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2012-12-19 |
4 |
S |
$4.04 |
$194,414 |
D/D |
(48,146) |
1,616,933 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2014-10-30 |
4 |
S |
$4.99 |
$195,769 |
D/D |
(39,200) |
1,203,359 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-10 |
4 |
S |
$6.68 |
$195,964 |
D/D |
(29,336) |
865,085 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2014-04-01 |
4 |
S |
$4.74 |
$203,353 |
D/D |
(42,869) |
1,452,852 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2014-04-01 |
4 |
S |
$4.74 |
$203,353 |
D/D |
(42,869) |
1,452,852 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2006-10-02 |
4 |
AS |
$4.30 |
$205,480 |
D/D |
(45,590) |
1,624,446 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2011-03-30 |
4 |
AS |
$6.08 |
$226,769 |
D/D |
(37,300) |
1,485,302 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2012-12-20 |
4 |
OE |
$3.16 |
$232,548 |
D/D |
73,591 |
1,690,524 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2011-03-29 |
4 |
AS |
$6.01 |
$245,392 |
D/D |
(40,800) |
1,522,602 |
0 |
- |
|
| BSTG |
Biostage Inc |
Interim CEO |
• • – |
2021-11-26 |
4 |
B |
$3.45 |
$250,001 |
D/D |
72,464 |
95,516 |
2.81 |
% |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-02-09 |
4 |
S |
$5.25 |
$255,738 |
D/D |
(48,712) |
894,421 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2006-04-04 |
4 |
AS |
$4.00 |
$255,848 |
D/D |
(63,900) |
1,970,036 |
|
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2006-10-04 |
4 |
AS |
$4.30 |
$272,474 |
D/D |
(63,125) |
1,486,006 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2014-12-19 |
4 |
S |
$5.01 |
$274,438 |
D/D |
(54,778) |
1,115,121 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-22 |
4 |
S |
$6.07 |
$282,061 |
D/D |
(46,468) |
647,753 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-06-01 |
4 |
OE |
$3.64 |
$287,775 |
D/D |
79,059 |
581,284 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-06-01 |
4 |
D |
$3.83 |
$292,512 |
D/D |
(76,374) |
504,910 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2012-12-20 |
4 |
S |
$4.05 |
$298,139 |
D/D |
(73,591) |
1,616,933 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2006-10-03 |
4 |
AS |
$4.30 |
$326,362 |
D/D |
(75,315) |
1,549,131 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-04-21 |
4 |
S |
$6.33 |
$338,104 |
D/D |
(53,413) |
694,221 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2014-10-29 |
4 |
S |
$4.96 |
$360,074 |
D/D |
(72,562) |
1,242,559 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2013-10-18 |
4 |
OE |
$2.98 |
$372,500 |
D/D |
125,000 |
1,483,507 |
0 |
- |
|
| BSTG |
Biostage Inc |
Interim CEO |
• • – |
2022-05-12 |
4 |
B |
$5.92 |
$375,002 |
D/D |
63,345 |
158,861 |
2.81 |
% |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2006-03-22 |
4 |
AS |
$3.92 |
$400,140 |
D/D |
(100,000) |
2,170,036 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
President |
• • – |
2006-10-27 |
4 |
AS |
$4.75 |
$452,372 |
D/D |
(94,963) |
1,375,073 |
0 |
- |
|
136 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
